Chronic cadmium exposure induces transcriptional activation of the Wnt pathway and upregulation of epithelial-to-mesenchymal transition markers in mouse kidney

Toxicology Letters

Volumn 198, Issue 1, 2010, Pages 69-76

  Chakraborty, Prabir K ^a   Scharner, Bettina ^a   Jurasovic, Jasna ^b   Messner, Barbara ^c   Bernhard, David ^c   Thévenod, Frank ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cadmium; Cancer; EMT; Frizzled; Renal fibrosis; Wnt

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CADMIUM; CYCLIN D1; FRIZZLED PROTEIN; GLYCOPROTEIN P; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MYC PROTEIN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYCLIN D1 GENE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE; GENE EXPRESSION REGULATION; KIDNEY FIBROSIS; KNOCKOUT MOUSE; LONG TERM EXPOSURE; MOUSE; NEPHROTOXICITY; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 77955573840     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.05.007     Document Type: Article

References (60)

1. Achanzar W.E., Achanzar K.B., Lewis J.G., Webber M.M., Waalkes M.P. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol. Appl. Pharmacol. 2000, 164:291-300.
2. Alao J.P. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 2007, 6:24.
3. Asar M., Kayisli U.A., Izgut-Uysal V.N., Akkoyunlu G. Immunohistochemical and ultrastructural changes in the renal cortex of cadmium-treated rats. Biol. Trace Elem. Res. 2004, 97:249-263.
4. Beyersmann D., Hartwig A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch. Toxicol. 2008, 82:493-512.
5. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103:311-320.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Bridges C.C., Zalups R.K. Molecular and ionic mimicry and the transport of toxic metals. Toxicol. Appl. Pharmacol. 2005, 204:274-308.
8. Cabrera C.V., Alonso M.C., Johnston P., Phillips R.G., Lawrence P.A. Phenocopies induced with antisense RNA identify the wingless gene. Cell 1987, 50:659-663.
9. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
10. Elsaid A.F., Delot E.C., Collins M.D. Differential perturbation of the Fgf/Erk1/2 and Shh pathways in the C57BL/6N and SWV embryonic limb buds after mid-gestational cadmium chloride administration. Mol. Genet. Metab. 2007, 92:258-270.
11. Filali M., Cheng N., Abbott D., Leontiev V., Engelhardt J.F. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem. 2002, 277:33398-33410.
12. Geserick P., Kaiser F., Klemm U., Kaufmann S.H., Zerrahn J. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int. Immunol. 2004, 16:1535-1548.
13. Gradl D., Kuhl M., Wedlich D. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol. Cell. Biol. 1999, 19:5576-5587.
14. Guillen-Ahlers H. Wnt signaling in renal cancer. Curr. Drug Targets 2008, 9:591-600.
15. Gumz M.L., Zou H., Kreinest P.A., Childs A.C., Belmonte L.S., LeGrand S.N., Wu K.J., Luxon B.A., Sinha M., Parker A.S., Sun L.Z., Ahlquist D.A., Wood C.G., Copland J.A. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin. Cancer Res. 2007, 13:4740-4749.
16. Hanson M.L., Brundage K.M., Schafer R., Tou J.C., Barnett J.B. Prenatal cadmium exposure dysregulates sonic hedgehog and Wnt/beta-catenin signaling in the thymus resulting in altered thymocyte development. Toxicol. Appl. Pharmacol. 2010, 242:136-145.
17. He W., Dai C., Li Y., Zeng G., Monga S.P., Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 2009, 20:765-776.
18. Howe L.R., Watanabe O., Leonard J., Brown A.M. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 2003, 63:1906-1913.
19. Huff J., Lunn R.M., Waalkes M.P., Tomatis L., Infante P.F. Cadmium-induced cancers in animals and in humans. Int. J. Occup. Environ. Health 2007, 13:202-212.
20. Iglesias D.M., Hueber P.A., Chu L., Campbell R., Patenaude A.M., Dziarmaga A.J., Quinlan J., Mohamed O., Dufort D., Goodyer P.R. Canonical WNT signaling during kidney development. Am. J. Physiol. Renal Physiol. 2007, 293:F494-F500.
21. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 2009, 119:1417-1419.
22. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
23. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
24. Katoh M. WNT3-WNT14B and WNT3A-WNT14 gene clusters (review). Int. J. Mol. Med. 2002, 9:579-584.
25. Kazantzis G. Cadmium, osteoporosis and calcium metabolism. Biometals 2004, 17:493-498.
26. Kordes C., Sawitza I., Haussinger D. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem. Biophys. Res. Commun. 2008, 367:116-123.
27. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
28. Lorenowicz M.J., Korswagen H.C. Sailing with the Wnt: charting the Wnt processing and secretion route. Exp. Cell Res. 2009, 315:2683-2689.
29. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
30. Messner B., Knoflach M., Seubert A., Ritsch A., Pfaller K., Henderson B., Shen Y.H., Zeller I., Willeit J., Laufer G., Wick G., Kiechl S., Bernhard D. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1392-1398.
31. Mignogna C., Staibano S., Altieri V., De Rosa G., Pannone G., Santoro A., Zamparese R., D'Armiento M., Rocchetti R., Mezza E., Nasti M., Strazzullo V., Montanaro V., Mascolo M., Bufo P. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis. BMC Cancer 2006, 6:293.
32. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25:7469-7481.
33. Okoye U.C., Malbon C.C., Wang H.Y. Wnt and Frizzled RNA expression in human mesenchymal and embryonic (H7) stem cells. J. Mol. Signal. 2008, 3:16.
34. Pendas-Franco N., Garcia J.M., Pena C., Valle N., Palmer H.G., Heinaniemi M., Carlberg C., Jimenez B., Bonilla F., Munoz A., Gonzalez-Sancho J.M. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene 2008, 27:4467-4477.
35. Pesch B., Haerting J., Ranft U., Klimpel A., Oelschlagel B., Schill W. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int. J. Epidemiol. 2000, 29:1014-1024.
36. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
37. Pulkkinen K., Murugan S., Vainio S. Wnt signaling in kidney development and disease. Organogenesis 2008, 4:55-59.
38. Qiao L.F., Xu Y.J., Liu X.S., Xie J.G., Wang J., Du C.L., Zhang J., Ni W., Chen S.X. Role of protein kinase C alpha and cyclin D1 in the proliferation of airway smooth muscle in asthmatic rats. Chin. Med. J. (Engl.) 2008, 121:2070-2076.
39. Rijsewijk F., Schuermann M., Wagenaar E., Parren P., Weigel D., Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987, 50:649-657.
40. Rubin J.S., Bottaro D.P. Loss of secreted frizzled-related protein-1 expression in renal cell carcinoma reveals a critical tumor suppressor function. Clin. Cancer Res. 2007, 13:4660-4663.
41. Saitoh T., Hirai M., Katoh M. Molecular cloning and characterization of human Frizzled-8 gene on chromosome 10p11.2. Int. J. Oncol. 2001, 18:991-996.
42. Satarug S., Garrett S.H., Sens M.A., Sens D.A. Cadmium, environmental exposure, and health outcomes. Environ. Health Perspect. 2010, 118:182-190.
43. Schiller M., Javelaud D., Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J. Dermatol. Sci. 2004, 35:83-92.
44. Scott W.J., Schreiner C.M., Goetz J.A., Robbins D., Bell S.M. Cadmium-induced postaxial forelimb ectrodactyly: association with altered sonic hedgehog signaling. Reprod. Toxicol. 2005, 19:479-485.
45. Teng S., Piquette-Miller M. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J. Pharmacol. Exp. Ther. 2005, 312:841-848.
46. Terasaki H., Saitoh T., Shiokawa K., Katoh M. Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT-beta-catenin-TCF signaling pathway. Int. J. Mol. Med. 2002, 9:107-112.
47. Thévenod F. Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron Physiol. 2003, 93:87-93.
48. Thévenod F. Cadmium and cellular signaling cascades: to be or not to be?. Toxicol. Appl. Pharmacol. 2009, 238:221-239.
49. Thévenod F., Friedmann J.M., Katsen A.D., Hauser I.A. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J. Biol. Chem. 2000, 275:1887-1896.
50. Thévenod F., Wolff N.A., Bork U., Lee W.K., Abouhamed M. Cadmium induces nuclear translocation of beta-catenin and increases expression of c-myc and Abcb1a in kidney proximal tubule cells. Biometals 2007, 20:807-820.
51. Thijssen S., Lambrichts I., Maringwa J., Van Kerkhove E. Changes in expression of fibrotic markers and histopathological alterations in kidneys of mice chronically exposed to low and high Cd doses. Toxicology 2007, 238:200-210.
52. Thijssen S., Maringwa J., Faes C., Lambrichts I., Van Kerkhove E. Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early renal damage, not predicted by blood or urine cadmium levels. Toxicology 2007, 229:145-156.
53. Thompson J., Wong L., Lau P.S., Bannigan J. Adherens junction breakdown in the periderm following cadmium administration in the chick embryo: distribution of cadherins and associated molecules. Reprod. Toxicol. 2008, 25:39-46.
54. Thuault S., Valcourt U., Petersen M., Manfioletti G., Heldin C.H., Moustakas A. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 2006, 174:175-183.
55. Ueno K., Hiura M., Suehiro Y., Hazama S., Hirata H., Oka M., Imai K., Dahiya R., Hinoda Y. Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia 2008, 10:697-705.
56. Vlad A., Rohrs S., Klein-Hitpass L., Muller O. The first five years of the Wnt targetome. Cell. Signal. 2008, 20:795-802.
57. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
58. Yu R.M., Lin C.C., Chan P.K., Chow E.S., Murphy M.B., Chan B.P., Muller F., Strahle U., Cheng S.H. Four-dimensional imaging and quantification of gene expression in early developing zebrafish (Danio rerio) embryos. Toxicol. Sci. 2006, 90:529-538.
59. Zadelaar S., Kleemann R., Verschuren L., de Vries-Van der Weij J., van der Hoorn J., Princen H.M., Kooistra T. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1706-1721.
60. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.